Chart of the Day: Singapore’s healthcare stocks experience two-year trading highs

Valuations on a broad-based level do not seem attractive.

The FTSE ST Health Care Index (FSTHC) has been performing better than the FSSTI with an 8.1% YTD gain as compared to FSSTI’s marginal 0.02% YTD gain.

According to OCBC, within their coverage, there is a mixed showing in share price performance for BIG and RFMD.

BIG’s price recovery earlier in the year was believed to be mainly supported by share buybacks as it gained 18.8% YTD, while RFMD’s price movement has been largely muted.

Among the selected companies, Q&M Dental group’s share price saw a 15.4% growth, which OCBC thinks was underpinned by a robust showing in the group’s FY14 earnings.

In contrast, QT Vascular recorded a YTD loss of 17.5% in its share price. While its FY14 revenue rose 140.7% to US$13.2m, the group saw another year of net loss of US$34.2m as it is still in a ramp-up phase.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia